1. Home
  2. MDV vs MIST Comparison

MDV vs MIST Comparison

Compare MDV & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Modiv Industrial Inc. Class C

MDV

Modiv Industrial Inc. Class C

HOLD

Current Price

$14.56

Market Cap

147.6M

ML Signal

HOLD

Logo Milestone Pharmaceuticals Inc.

MIST

Milestone Pharmaceuticals Inc.

HOLD

Current Price

$2.68

Market Cap

163.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDV
MIST
Founded
2015
2003
Country
United States
Canada
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
147.6M
163.2M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
MDV
MIST
Price
$14.56
$2.68
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.33
AVG Volume (30 Days)
30.1K
3.4M
Earning Date
11-14-2025
11-12-2025
Dividend Yield
8.04%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$47,479,000.00
N/A
Revenue This Year
$0.13
N/A
Revenue Next Year
$0.71
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.62
$0.63
52 Week High
$17.15
$2.77

Technical Indicators

Market Signals
Indicator
MDV
MIST
Relative Strength Index (RSI) 49.37 70.83
Support Level $14.50 $2.52
Resistance Level $14.83 $2.75
Average True Range (ATR) 0.33 0.19
MACD 0.00 0.03
Stochastic Oscillator 58.86 86.54

Price Performance

Historical Comparison
MDV
MIST

About MDV Modiv Industrial Inc. Class C

Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: